Nisa Investment Advisors
ALDX icon

Nisa Investment Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Nisa Investment Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392 Sell
184
-4,416
-96% -$7.59K ﹤0.01% 2973
2026
Q1 		$7.77K Buy
4,600
+4,503
+4,642% +$19.7K ﹤0.01% 2328
2025
Q4 		$502 Hold
97
– – ﹤0.01% 2818
2025
Q3 		$506 Hold
97
– – ﹤0.01% 2858
2025
Q2 		$372 Sell
97
-1,533
-94% -$3.96K ﹤0.01% 2916
2025
Q1 		$9.37K Buy
1,630
+49
+3% +$290 ﹤0.01% 2110
2024
Q4 		$7.89K Buy
1,581
+88
+6% +$452 ﹤0.01% 2183
2024
Q3 		$8.05K Buy
1,493
+42
+3% +$200 ﹤0.01% 2133
2024
Q2 		$4.8K Buy
1,451
+1,396
+2,538% +$5.47K ﹤0.01% 2273
2024
Q1 		$180 Buy
55
+15
+38% +$49 ﹤0.01% 2658
2023
Q4 		$140 Buy
+40
New +$123 ﹤0.01% 2595
2022
Q2 		– Sell
-50,600
Closed -$225K – 2370
2022
Q1 		$225K Buy
+50,600
New +$202K ﹤0.01% 1336

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Nisa Investment Advisors's ALDX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Aldeyra Therapeutics (ALDX) stake by 96% in Q2 2026, selling an estimated $7.59K and leaving 184 shares worth $392. The position accounts for ﹤0.01% of the portfolio, ranked #2973.

Nisa Investment Advisors first reported a position in ALDX in Q1 2022 and has held it in 12 quarters since. The position peaked at $225K in Q1 2022. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Nisa Investment Advisors held 184 shares of Aldeyra Therapeutics worth $392 as of Q2 2026.
  • Nisa Investment Advisors sold 4,416 Aldeyra Therapeutics shares in Q2 2026, an estimated $7.59K.
  • Aldeyra Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2973 holding.
  • Nisa Investment Advisors first reported a position in Aldeyra Therapeutics in Q1 2022 and has held it in 12 quarters since.
  • Nisa Investment Advisors's Aldeyra Therapeutics position peaked at $225K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.